Safety of Gastroenterologist-Guided Sedation with Propofol for Upper Gastrointestinal Therapeutic Endoscopy in Elderly Patients Compared with Younger Patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Propofol sedation for elderly patients during time-consuming endoscopic procedures is controversial. Therefore, we investigated the safety of using propofol in elderly patients during upper gastrointestinal therapeutic endoscopy. Methods: The medical records of 160 patients who underwent therapeutic endoscopic procedures under gastroenterologist- guided propofol sedation at a single institution were retrospectively reviewed. The subjects were divided into two groups: a younger group, patients <75 years old; and an elderly group, patients ≥75 years old. The two groups were compared with respect to the therapeutic regimen, circulatory dynamics, and presence/absence of discontinuation of propofol treatment. Results: Although the number of patients with liver dysfunction was higher in the elderly group, there were no other significant differences in the baseline characteristics, including the American Society of Anesthesiologists classification, between the elderly and younger groups. The average maintenance rate of continuous propofol infusion was lower in the elderly patients. No statistically significant differences were found in the occurrence of adverse events between the elderly and younger groups. None of the patients returned to a resedated state after the initial recovery from sedation. Conclusions: Gastroenterologist-guided propofol sedation in elderly patients can be safely achieved in the same manner as that in younger patients, even for timeconsuming upper gastrointestinal therapeutic endoscopic procedures.
Abstract
Background/Aims: Propofol sedation for elderly patients during time-consuming endoscopic procedures is controversial. Therefore, we investigated the safety of using propofol in elderly patients during upper gastrointestinal therapeutic endoscopy. Methods: The medical records of 160 patients who underwent therapeutic endoscopic procedures under gastroenterologist- guided propofol sedation at a single institution were retrospectively reviewed. The subjects were divided into two groups: a younger group, patients <75 years old; and an elderly group, patients ≥75 years old. The two groups were compared with respect to the therapeutic regimen, circulatory dynamics, and presence/absence of discontinuation of propofol treatment. Results: Although the number of patients with liver dysfunction was higher in the elderly group, there were no other significant differences in the baseline characteristics, including the American Society of Anesthesiologists classification, between the elderly and younger groups. The average maintenance rate of continuous propofol infusion was lower in the elderly patients. No statistically significant differences were found in the occurrence of adverse events between the elderly and younger groups. None of the patients returned to a resedated state after the initial recovery from sedation. Conclusions: Gastroenterologist-guided propofol sedation in elderly patients can be safely achieved in the same manner as that in younger patients, even for timeconsuming upper gastrointestinal therapeutic endoscopic procedures.
참고문헌 (26)
- Cohen LB, "Endoscopic sedation in the United States: results from a nationwide survey", Am J Gastroenterol, 101, pp.967~974 (2006)
- Heuss LT, "Nonanesthesiologist-administered propofol sedation: from the exception to standard practice:sedation and monitoring trends over 20 years", Endoscopy, 44, pp.504~511 (2012)
- Rex DK, "Endoscopist-directed administration of propofol: a worldwide safety experience", Gastroenterology, 137, pp.1229~1237 (2009)
- Rex DK, "Trained registered nurses", endoscopy teams can administer propofol safely for endoscopy, 2005, pp.129, 1384~1391
- Heuss LT, "Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases", Gastrointest Endosc, 57, pp.664~671 (2003)
- Tohda G, "Propofol sedation during endoscopic procedures: safe and effective administration by registered nurses supervised by endoscopists", Endoscopy, 38, pp.360~367 (2006)
- Qadeer MA, "Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis", Clin Gastroenterol Hepatol, 3, pp.1049~1056 (2005)
- McQuaid KR, "A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures", Gastrointest Endosc, 67, pp.910~923 (2008)
- Schilling D, "Sedation with propofol for interventional endoscopy by trained nurses in high-risk octogenarians: a prospective, randomized, controlled study", Endoscopy, 41, pp.295~298 (2009)
- Lee CK, "Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study", Gastrointest Endosc, 73, pp.206~214 (2011)
- Manolaraki MM, "Sedation in gastrointestinal endoscopies (Part 1)", Ann Gastroenterol, 22, pp.90~96 (2009)
- Paspatis GA, "Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study", Am J Gastroenterol, 97, pp.1963~1967 (2002)
- Vargo JJ, "Gastroenterologistadministered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial", Gastroenterology, 123, pp.8~16 (2002)
- Sipe BW, "Propofol versus midazolam", meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists, 2002, pp.55, 815~825
- Horiuchi A, "Safety and driving ability following low-dose propofol sedation", Digestion, 78, pp.190~194 (2008)
- Horiuchi A, "Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy:results in 10,662 adults", Am J Gastroenterol, 104, pp.1650~1655 (2009)
- Cohen LB, "Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine", fentanyl, and midazolam, 2004, pp.59, 795~803
- Cohen LB, "Propofol for endoscopic sedation: a protocol for safe and effective administration by the gastroenterologist", Gastrointest Endosc, 58, pp.725~732 (2003)
- Kongkam P, "Propofol infusion versus intermittent meperidine and midazolam injection for conscious sedation in ERCP", J Gastrointestin Liver Dis, 17, pp.291~297 (2008)
- Kiriyama S, "Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection", J Gastroenterol, 45, pp.831~837 (2010)
- Yamagata T, "Efficacy of propofol sedation for endoscopic submucosal dissection (ESD): assessment with prospective data collection", Intern Med, 50, pp.1455~1460 (2011)
- Qadeer MA, "Hypoxemia during moderate sedation for gastrointestinal endoscopy: causes and associations", Digestion, 84, pp.37~45 (2011)
- Agostoni M, "Adverse events during monitored anesthesia care for GI endoscopy:an 8-year experience", Gastrointest Endosc, 74, pp.266~275 (2011)
- Gasparović S, "Clinical analysis of propofol deep sedation for 1,104 patients undergoing gastrointestinal endoscopic procedures: a three year prospective study", World J Gastroenterol, 12, pp.327~330 (2006)
- Park CH, "Risk factors and prognosis of pulmonary complications after endoscopic submucosal dissection for gastric neoplasia", Dig Dis Sci, 58, pp.540~546 (2013)
- Klotz U, "Pharmacokinetics and drug metabolism in the elderly", Drug Metab Rev, 41, pp.67~76 (2009)